Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RubaTinA-asthma: Tiotropium in Adolescents with Moderate Asthma
NCT01257230Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of tiotropium in asthma, sponsored by Boehringer Ingelheim. Started Dec 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01257230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257230.